Literature DB >> 19821513

A routinely applicable way for using FCM in cell enumeration with CFSE-labeled CellBeads as internal standard.

Fan-Fan Cao, Li-Min Xu, Bin Peng, Qiu-Hua Xie, Georges Uzan, Deng-Hai Zhang.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19821513     DOI: 10.1002/cyto.a.20809

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


× No keyword cloud information.
  5 in total

1.  Clinical significance of 5-(and 6)-carboxyfluorescein diacetate succinimidyl ester-labeled microspheres for detecting endothelial progenitor cells in human peripheral blood.

Authors:  Chaolin Qiu; Denghai Zhang; Yongbin Chi; Qing Chen; Limin Xu; Qiuhua Xie
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

2.  HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.

Authors:  Bin Peng; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Denghai Zhang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

3.  Celastrol inhibits lung infiltration in differential syndrome animal models by reducing TNF-α and ICAM-1 levels while preserving differentiation in ATRA-induced acute promyelocytic leukemia cells.

Authors:  Li-min Xu; Yue-juan Zheng; Ying Wang; Yang Yang; Fan-fan Cao; Bin Peng; Xiong-fei Xu; Hua-zhang An; Ao-xiang Zheng; Deng-hai Zhang; Georges Uzan; Yi-zhi Yu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

4.  Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol.

Authors:  Lu Cao; Xue Zhang; Fanfan Cao; Ying Wang; Yufan Shen; Chunxin Yang; Georges Uzan; Bin Peng; Denghai Zhang
Journal:  BMC Cancer       Date:  2015-11-09       Impact factor: 4.430

5.  Peptide deformylase inhibitor actinonin reduces celastrol's HSP70 induction while synergizing proliferation inhibition in tumor cells.

Authors:  Bin Peng; Xue Zhang; Fanfan Cao; Ying Wang; Limin Xu; Lu Cao; Chunxin Yang; Maoquan Li; Georges Uzan; Denghai Zhang
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.